Schizophrenia and sudden cardiac death - A review

Nordic Journal of Psychiatry

Volumn 62, Issue 5, 2008, Pages 342-345

  Koponen, Hannu ^a   Alaräisänen, Antti ^b   Saari, Kaisa ^b   Pelkonen, Olavi ^b   Huikuri, Heikki ^b   Raatikainen, M J Pekka ^b   Savolainen, Markku ^b   Isohanni, Matti ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Antipsychotic medication; Arrhythmias; Autonomic dysfunction; Mortality; Schizophrenia; Sudden death; Torsades de pointes

Indexed keywords

AMIODARONE; AMISULPRIDE; CLOZAPINE; DROPERIDOL; FLUPHENAZINE; HALOPERIDOL; IBUTILIDE; MACROLIDE; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; QUETIAPINE; QUINIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RISPERIDONE; SERTINDOLE; SOTALOL; SULPIRIDE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; ZIPRASIDONE; ZOTEPINE;

ACCIDENT; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASE; FOLLOW UP; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; LIFE EXPECTANCY; MEDLINE; METABOLIC DISORDER; MORTALITY; PREVALENCE; QT PROLONGATION; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SIDE EFFECT; SUDDEN DEATH; SUICIDE; TORSADE DES POINTES;

ANTIPSYCHOTIC AGENTS; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DIET; HUMANS; LIFE STYLE; LONG QT SYNDROME; OBESITY; RISK FACTORS; SCHIZOPHRENIA; SMOKING;

EID: 52649102539     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.1080/08039480801959323     Document Type: Review

References (36)

1. Mortensen, PB. (2003) Mortality and physical illness in schizophrenia. The epidemiology of schizophrenia, Cambridge University Press, Cambridge
2. Brown, S., Inskip, H. and Barraclough, B. (2000) Causes of excess mortality of schizophrenia. Br J Psychiatry, 177, pp. 212-217.
3. Bandelow, B., Fritze, J. and Ruther, E. (1998) Increased mortality in schizophrenia and the possible influence of antipsychotic treatment. Int J Psych Clin Pract, 2, pp. S49-S57.
4. Straus, SMJM, Bleumink, GS, Dieleman, JP, van der Lei, J., Stricker, BHC and Sturkenboom, MCJM. (2004) The incidence of sudden cardiac death in general population. J Clin Epidemiol, 57, pp. 98-102.
5. Jindal, R., MacKenzie, EM, Baker, GB and Yeragani, VK. (2005) Cardiac risk and schizophrenia. J Psychiatry Neurosci, 30, pp. 393-395.
6. Zipes, DP and Wellens, HJJ. (1998) Sudden cardiac death. Circulation, 98, pp. 2334-2351.
7. Heila, H., Haukka, J., Suvisaari, J. and Lönnqvist, J. (2005) Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med, 35, pp. 725-732.
8. Chute, D., Grove, C., Rajasekhara, B. and Smialek, JE. (1999) Schizophrenia and sudden death: A medical examiner case study. Am J Forensic Med Pathol, 20, pp. 131-135.
9. Ösby, U., Correia, N., Brandt, L., Ekbom, A. and Sparen, P. (2000) Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Sch Research, 45, pp. 21-28.
10. Stark, C., MacLeod, M., Hall, D., O'Brien, F. and Pelosi, A. (2003) Mortality after discharge from long-term psychiatric care in Scotland, 1977-94: A retrospective cohort study. BMC Public Health, 3, pp. 30-34.
11. Appleby, L., Thomas, S., Ferrier, N., Lewis, G., Shaw, J. and Amos, T. (2000) Sudden unexplained death in psychiatric in-patients. Br J Psychiatry, 176, pp. 405-406.
12. Ruschena, D., Mullen, PE, Burgess, P., Cordner, SM, Barry-Walsh, J. Drummer, OH et al. (1998) Sudden death in psychiatric patients. Br J Psychiatry, 172, pp. 331-336.
13. Mehtonen, OP, Aranko, K., Malkonen, L. and Vapaatalo, H. (1991) A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psych Scand, 84, pp. 58-64.
14. Ray, WA, Meredith, S., Thapa, PB, Meador, KG, Hall, K. and Murray, KT. (2001) Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry, 58, pp. 1161-1167.
15. Hennessy, S., Bilker, WB, Knauss, JS, Margolis, DJ, Kimmel, SE Reynolds, RF et al. (2002) Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data. BMJ, 325, pp. 1070-1072.
16. Reilly, JG, Ayis, SA, Ferrier, IN, Jones, SJ and Thomas, SHL. (2002) Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry, 180, pp. 515-522.
17. Waddington, JL, Youssef, HA and Kinsella, A. (1998) Mortality in schizophrenia. Antipsychotic polypharmacy and the absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry, 173, pp. 325-329.
18. Joukamaa, M., Heliovaara, M., Knekt, P., Aromaa, A., Raitasalo, R. and Lehtinen, V. (2006) Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry, 188, pp. 122-127.
19. La Rovere, MT, Bersano, C., Gnemmi, M., Specchia and Schwartz, PJ (2002) Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation, 106, pp. 945-949.
20. Huikuri, HV, Makikallio, TH, Peng, C-K, Goldberg, AL, Hintze, U. and Moller, M. (2000) Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation, 101, pp. 47-53.
21. Huikuri, HV, Mäkikallio, TH, Raatikainen, MJP, Perkiömäki, J., Castellanos, A. and Myerburg, RJ. (2003) Prediction of sudden cardiac death: Appraisal of the studies and methods assessing sudden arrhythmic death. Circulation, 108, pp. 110-115.
22. Bar, KJ, Letzsch, A., Jochum, T., Wagner, G., Greiner, W. and Sauer, H. (2005) Loss of efferent vagal activity in acute schizophrenia. J Psychiatry Res, 39, pp. 519-527.
23. Williams, LM, Das, P., Harris, AW, Liddell, BB, Brammer, MJ Olivieri, G. et al. (2004) Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry, 161, pp. 480-489.
24. Ridler, K., Veijola, JM, Tanskanen, P., Miettunen, J., Chitnis, X. Sucling, J. et al. (2006) Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proc Natl Acad Sci USA, 103, pp. 15651-15656.
25. Davatzikos, C., Shen, D., Gur, RC, Wu, X., Liu, D. Fan, Y. et al. (2005) Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry, 62, pp. 1218-1227.
26. Crithley, HD, Taggart, P., Sutton, PM, Holdright, DR, Batchvarov, V. Hnatkova, K. et al. (2005) Mental stress and sudden cardiac death: Asymmetric midbrain activity as a linking mechanism. Brain, 128, pp. 75-85.
27. Cohen, H., Loewenthal, U., Mater, M. and Kotler, M. (2001) Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry, 179, pp. 167-171.
28. Silke, B., Cambell, C. and King, DJ. (2002) The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability. J Psychopharmacol, 16, pp. 355-360.
29. Kang, UG, Kwon, JS Ahn, YM et al. (2000) Electrocardiographic abnormalities in patients treated with clozapine. J Clin Psychiatry, 61, pp. 441-446.
30. Glassman, AH and Bigger, JT. (2001) Antipsychotic drugs: Prolonged QTc interval, torsades de pointes, and sudden death. Am J Psychiatry, 158, pp. 1774-1782.
31. Titier, K., Girodet, P-O Verdoux, H. et al. (2005) Atypical antipsychotics. From potassium channels to Torsade de Pointes and sudden death. Drug Safety, 28, pp. 35-51.
32. Hassaballa, HA and Balk, RA. (2003) Torsades de pointes associated with the administration of intravenous haloperidol. Am J Therapeutics, 10, pp. 58-60.
33. Welch, R. and Chue, P. (2000) Antipsychotic agents and QT changes. J Psychiatry Neurosci, 25, pp. 154-160.
34. Kelly, DL and Love, RC. (2001) Ziprasidone and the OTc interval: Pharmacokinetic and pharmacodynamic considerations. Psychopharmacol Bull, 35, pp. 66-79.
35. Kiviniemi, AM, Tulppo, MP, Wichterle, D., Hautala, AJ, Tiinanen, S. Seppänen, T. et al. (2007) Novel spectral indexes of heart rate variability as predictors of sudden and non-sudden cardiac death after an acute myocardial infarction. Ann Med, 39, pp. 54-62.
36. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27, pp. 596-601.